Trinity Biotech (TRIBY) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY)

TRIB 0.890

+0.6%

Nov 25 3:57 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bob Jagow who wrote (8789)	3/27/1998 11:13:00 AM
From: Keiko	Read Replies (2) of 14328

Bob, We have to keep all these tests in the proper perspectives and keep in mind the three distinct market segments as it applies to HIV testing 1 ) Laboratory Medicine..... Abbott Labs is the Big kid on the block and multiple, laboratory- setting testing will still occur, and Abbott will continue to dominate. 2 ) POCTesting.....many players and nobody at Trinity is under any illusions about where the markets are and who the major players. Trinity will be one, but not the only winner. 3 ) the huge OTC markets Abbott Labs has two whole blood fingerstick- type tests now in clinical trials and is eager to bring the tests to market. TRIBY... nice volume and that buyer is sitting on the bid 50 X 5

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next